Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 10/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7044585 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL182466 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL7044918 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL9354133 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL1354834 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL11445128 | 0.97 | SMN1; SMN2 (0.43) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL10703302 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL8205797 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL20873213 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 | |
| SCHEMBL2789146 | 0.97 | LMNA (0.48) | SMN1; SMN2LMNAALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106164082-B | Method for preparing cyclic phosphonate, cyclic phosphonate prepared by the method, and industrial article comprising the cyclic phosphonate | ICL-IP美国有限公司 | 2020-05-19 | — | — | CN | claimed |
| US-20170174714-A1 | PROCESS OF PREPARING CYCLIC PHOSPHONATE ESTER, CYCLIC PHOSPHONATE ESTER PREPARED THEREFROM AND INDUSTRIAL APPLICATIONS CONTAINING THE SAME | ICL-IP America Inc | 2017-06-22 | — | — | US | claimed |
| EP-3585620-B1 | 3D PRINTING DEVICES INCLUDING MIXING NOZZLES | KORNIT DIGITAL TECH LTD (IL) | 2024-05-15 | — | — | EP | disclosed |
| US-11857023-B2 | Digital molding and associated articles and methods | KORNIT DIGITAL TECHNOLOGIES LTD. (IL) | 2024-01-02 | — | — | US | disclosed |
| US-11845217-B2 | 3D-printing using reactive precursors | KORNIT DIGITAL TECHNOLOGIES LTD. (IL) | 2023-12-19 | — | — | US | disclosed |
| US-11647805-B2 | 3D printed articles of footwear with sensors and methods of forming the same | KORNIT DIGITAL TECHNOLOGIES LTD. (IL) | 2023-05-16 | — | — | US | disclosed |
| US-11497275-B2 | 3D printed articles of footwear with particles | KORNIT DIGITAL TECHNOLOGIES LTD. (IL) | 2022-11-15 | — | — | US | disclosed |
| US-20220000212-A1 | DIGITAL MOLDING AND ASSOCIATED ARTICLES AND METHODS | Voxel8, Inc. (US) | 2022-01-06 | — | — | US | disclosed |
| US-20210321713-A1 | 3D PRINTED ARTICLES OF FOOTWEAR WITH SENSORS AND METHODS OF FORMING THE SAME | Voxel8, Inc. (US) | 2021-10-21 | — | — | US | disclosed |
| US-10932515-B2 | 3D printed articles of footwear with sensors and methods of forming the same | Voxel8, Inc. (US) | 2021-03-02 | — | — | US | disclosed |
| EP-3697593-A1 | 3D-PRINTING USING REACTIVE PRECURSORS | VOXEL8, INC. (US) | 2020-08-26 | — | — | EP | disclosed |
| EP-0908481-A1 | POLYURETHANES AND POLYESTER POLYOLS | Kyowa Yuka Co., Ltd. (JP) | 1999-04-14 | — | — | EP | disclosed |
| US-4824955-A | ANTITUMOR AGENTS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1989-04-25 | — | — | US | disclosed |
| EP-0222414-A2 | Novel organic selenium compounds | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-05-20 | — | — | EP | disclosed |
| US-4557913-A | Borax recovery using sodium metaborate and boric acid intermediates | KERR-MCGEE CHEMICAL CORPORATION (US) | 1985-12-10 | — | — | US | disclosed |
| US-4218362-A | Powder marking agent and marking method | FUJI PHOTO FILM CO., LTD. (JP) | 1980-08-19 | — | — | US | disclosed |
| US-4045485-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC AND ANTIPRURITIC ACTIVITY | SYNTEX CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-3960936-A | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, SKIN DISORDERS | SYNTEX CORPORATION (PM) | 1976-06-01 | — | — | US | disclosed |
| US-3947472-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC | SYNTEX CORPORATION (PM) | 1976-03-30 | — | — | US | disclosed |
| US-3935273-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC | SYNTEX CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174714-A1 | PROCESS OF PREPARING CYCLIC PHOSPHONATE ESTER, CYCLIC PHOSPHONATE ESTER PREPARED THEREFROM AND INDUSTRIAL APPLICATIONS CONTAINING THE SAME | NOTUM, PFKFB2, PFKFB1 | SMN1; SMN2 3793/4885LMNA 3231/4885ALDH1A1 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.